There’s been another merger in healthcare Big Data.
Wednesday, payer-facing SCIO Health Analytics, of West Hartford, Connecticut, said that it has acquired Westlake Village, California-based Clear Vision Information Systems, for an undisclosed sum.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
Clear Vision offers software-as-a-service analytics technology for risk adjustment and quality measurement. The 10-year-old company serves government and commercial health plans, care providers and Accountable Care Organizations.
“By combining Clear Vision’s robust risk adjustment and quality metric analytics, as well as its outreach services, with SCIO’s predictive and prescriptive analytics solutions and services focused on reimbursement and care optimization, we can help our clients manage this transition [to value-based care] more effectively while maximizing care quality, network performance and revenue,” SCIO Health Analytics CEO Siva Namasivayam said.
“The two sets of technologies dovetail nicely to deliver a well-rounded picture of the changes organizations need to make to achieve their goals,” added Clear Vision Founder, President and CEO Tom Peterson. Peterson and Clear Vision Co-founder Pam Klugman have been offered executive positions with SCIO, the companies said.
Photo: Bigstock
Changes in Nurse Staffing Answer Clinician Demands
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.